Previous immunosuppressive therapy is a risk factor for immune reconstitution inflammatory syndrome in Whipple's disease

Digestive and Liver Disease

Volumn 44, Issue 10, 2012, Pages 880-882

  Biagi, Federico ^a   Trotta, Lucia ^a   Di Stefano, Michele ^a   Balduzzi, Davide ^a   Marchese, Alessandra ^a   Vattiato, Claudia ^a   Bianchi, Paola I ^a   Fenollar, Florence ^b   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Chronic infection; Immune reconstitution inflammatory syndrome; Tropheryma whipplei

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; METHOTREXATE; STEROID;

ADULT; AGED; ARTHRALGIA; ARTICLE; BLOODSTREAM INFECTION; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE LIPODYSTROPHY; ITALY; MALE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE AGENTS; MALE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; TROPHERYMA; WHIPPLE DISEASE;

EID: 84865707514     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.05.008     Document Type: Article

References (21)

1. Fenollar F., Puéchal X., Raoult D. Whipple's disease. New England Journal of Medicine 2007, 356:55-66.
2. Schneider T., Moos V., Loddenkemper C., et al. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infectious Diseases 2008, 8:179-190.
3. Maiwald M., Schuhmacher F., Ditton H.J., et al. Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Applied and Environment Microbiology 1998, 64:760-762.
4. Zinkernagel A.S., Gmür R., Fenner L., et al. Marginal and subgingival plaque-a natural habitat of Tropheryma whipplei?. Infection 2003, 31:86-91.
5. Schöniger-Hekele M., Petermann D., Weber B., et al. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Applied and Environment Microbiology 2007, 73:2033-2035.
6. Fenollar F., Trani M., Davoust B., et al. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. Journal of Infectious Diseases 2008, 197:880-887.
7. Li W., Fennolar F., Rolain J.-M., et al. Genotyping reveals a wide heterogenity of Tropheryma whipplei. Microbiology 2008, 154:521-527.
8. Martinetti M., Biagi F., Badulli C., et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 2009, 136:2289-2294.
9. Moos V., Kunkel D., Marth T., et al. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease. Journal of Immunology 2006, 177:2015-2022.
10. Paulley J.W. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 1952, 22:128-133.
11. Keinath R.D., Merrell D.E., Vlietstra R., et al. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology 1985, 88:1867-1873.
12. Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010, 138:478-486.
13. Fenollar F., Raoult D., Infection: How should classic Whipple disease be managed?. Nature Reviews. Gastroenterology & Hepatology 2010, 7:246-248.
14. Lagier J.C., Fenollar F., Lepidi H., et al. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. Journal of Antimicrobial Chemotherapy 2010, 65:2005-2012.
15. Lagier J.C., Fenollar F., Lepidi H., et al. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide. Journal of Infection 2010, 60:79-82.
16. Feurle G.E., Moos V., Schinnerling K., et al. The immune reconstitution inflammatory syndrome in Whipple disease. A cohort study. Annals of Internal Medicine 2010, 153:710-717.
17. von Herbay A., Maiwald M., Ditton H.J., et al. Histology of intestinal Whipple's disease revisited. A study of 48 patients. Virchows Archiv 1996, 429:335-343.
18. Fenollar F., Laouira S., Lepidi H., et al. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clinical Infectious Diseases 2008, 47:659-667.
19. Lagier J.C., Fenollar F., Lepidi H., et al. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. Journal of Antimicrobial Chemotherapy 2011, 66:1188-1189.
20. Britton W.J., Lockwood D.N. Leprosy. The Lancet 2004, 363:1209-1219.
21. Mahnel R., Kalt A., Ring S., et al. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. American Journal of Gastroenterology 2005, 100:1167-1173.